CharlotteBienabe

Associate

Paris + 33.1.56.59.46.37

Charlotte Bienabe advises domestic and international clients on French and labor and employment matters both in counseling and in litigation proceedings.

She regularly advises companies on individual employment matters related to hiring employees, working time, high-level executive compensation, secondment, and expatriation and dismissal procedures for personal or economic grounds, as well as the settlement of subsequent litigation.

Charlotte also advises on collective matters related to the elections of employees' representatives and the consultation process related to employees' representatives, collective bargaining agreements, and restructurings.

She also represents French and international companies in individual and collective litigation before civil and criminal courts.

Charlotte has experience in audits on labor and employment issues related to M&A and venture capital transactions.

She advises global corporations in the metallurgy, energy, and pharmaceutical industries, as well as the IT sector.

Experience

  • CANDRIAM to acquire Rothschild & Co Asset Management Europe's alternative multi-asset management businessJones Day is advising CANDRIAM in the acquisition of Rothschild & Co Asset Management Europe’s alternative multi-asset management business.
  • GCA Altium acquires Stella EOCJones Day advised GCA Altium in the acquisition of Stella EOC, a technology and media investment banking boutique with coverage in the UK and Europe.
  • Wellington Partners, Bpifrance Investissement, CITA Investissement, Supernova Invest, b-to-v Partners, Hil-Invent, and Financière Arbevel participate in €16 million financing round of UroMemsJones Day represented Wellington Partners, Bpifrance Investissement, CITA Investissement, Supernova Invest, b-to-v Partners, Hil-Invent, and Financière Arbevel in connection with the €16 million new financing round of UroMems, a French medtech company focusing on designing, developing, and commercializing active implantable medical devices.
  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • PETRONAS Chemicals acquires Da Vinci Group B.V. for €163 millionJones Day advised PETRONAS Chemicals Group Berhad (PCG) in its acquisition of a 100% stake in Da Vinci Group B.V. from its shareholders including funds managed by Bencis Capital Partners for €163 million.
  • Inotrem raises €39 million in Series B financing roundJones Day advised Inotrem S.A., a French biotech company specialized in immunotherapy for acute and chronic inflammatory syndromes, in connection with its €39 million (US$43 million) Series B round of financing led by Morningside Ventures and joined by Invus as well as historical investors including Andera Partners, Sofinnova Partners, and BiomedInvest.
  • Arsenal Capital Partners acquires HistoGeneX and Caprion BiosciencesJones Day advised Arsenal Capital Partners on major investments in HistoGeneX and Caprion Biosciences and the subsequent combination of the two businesses.
  • Sommet Education acquires Ducasse EducationJones Day assisted Sommet Education, a portfolio company of Eurazeo, in its acquisition of a 51% interest in Ducasse Education, a major player in culinary arts and pastry training.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • Findos Investor acquires worldwide business of Röder HTS Höcker GmbHJones Day advised funds managed by Findos Investor in connection with acquisition of the entire worldwide business operations of Röder HTS Höcker GmbH.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Partech Partners and Elaia Partners invest in OpenIOJones Day represented Partech Partners and Elaia Partners in connection with their investment in OpenIO, a provider of object storage and serverless computing.
  • New Alpha invests in WiztopicJones Day represented New Alpha Asset Management in connection with its investment in Wiztopic SAS, a publisher of an SaaS solution dedicated to corporate and financial communication executives.
  • OEConnection Holdings acquires Clifford Thames GroupJones Day advised OEConnection Holdings, LLC in connection with its acquisition of Clifford Thames Group, a leader in automotive data creation and management with operations in Europe, the U.S., India, and Australia.
  • AccorHotels acquires AvailproJones Day advised AccorHotels, a French multinational hotel group, in connection with its acquisition of Availpro, a leading European software provider to hoteliers.
  • New Alpha and Aviva France invest €2.5 million in TrackInsightJones Day represented New Alpha Asset Management and Aviva France in connection with their €2.5 million (US$2.7 million) investment in TrackInsight, a French fintech company specialized in the development of a platform for ETF selection and analysis.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.